BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1510407)

  • 1. Effect of pooled human cerebrospinal fluid on the postantibiotic effects of cefotaxime, ciprofloxacin, and gentamicin against Escherichia coli.
    Zhanel GG; Karlowsky JA; Davidson RJ; Hoban DJ
    Antimicrob Agents Chemother; 1992 May; 36(5):1136-9. PubMed ID: 1510407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro postantibiotic effects following multiple exposures of cefotaxime, ciprofloxacin, and gentamicin against Escherichia coli in pooled human cerebrospinal fluid and Mueller-Hinton broth.
    Karlowsky JA; Zhanel GG; Davidson RJ; Zieroth SR; Hoban DJ
    Antimicrob Agents Chemother; 1993 May; 37(5):1154-7. PubMed ID: 8517705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of human urine on the in vitro activity and postantibiotic effect of ciprofloxacin against Escherichia coli.
    Zhanel GG; Karlowsky JA; Davidson RJ; Hoban DJ
    Chemotherapy; 1991; 37(3):218-23. PubMed ID: 1889309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postexposure factors influencing the duration of postantibiotic effect: significance of temperature, pH, cations, and oxygen tension.
    Fuursted K
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1693-6. PubMed ID: 9257743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the in vitro susceptibility of planktonic and biofilm-associated Escherichia coli strains to antimicrobial agents.
    Naves P; Del Prado G; Ponte C; Soriano F
    J Chemother; 2010 Oct; 22(5):312-7. PubMed ID: 21123153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postantibiotic effect of ciprofloxacin compared with that of five other quinolones.
    Minguez F; Ramos C; Barrientos S; Loscos A; Prieto J
    Chemotherapy; 1991; 37(6):420-5. PubMed ID: 1760941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bactericidal effect of cefotaxime-sulbactam and imipenem combined with gentamicin and/or ciprofloxacin against CTX-1 producing Klebsiella pneumoniae].
    Archambaud M; Labau E; Clave D; Suc C
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):534-9. PubMed ID: 2677925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
    Stamm JM; Hanson CW; Chu DT; Bailer R; Vojtko C; Fernandes PB
    Antimicrob Agents Chemother; 1986 Feb; 29(2):193-200. PubMed ID: 3087274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human serum enhances the postantibiotic effect of fluoroquinolones against Staphylococcus aureus.
    Davidson RJ; Zhanel GG; Phillips R; Hoban DJ
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1261-3. PubMed ID: 1929278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ampicillin, gentamicin, and cefotaxime on the release of Shiga toxins from Shiga toxin-producing Escherichia coli isolated during a diarrhea episode in Faisalabad, Pakistan.
    Mohsin M; Haque A; Ali A; Sarwar Y; Bashir S; Tariq A; Afzal A; Iftikhar T; Saeed MA
    Foodborne Pathog Dis; 2010 Jan; 7(1):85-90. PubMed ID: 19785532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Bile Reduces Antimicrobial Activity of Selected Antibiotics against Enterococcus faecalis and Escherichia coli
    Wulkersdorfer B; Jaros D; Eberl S; Poschner S; Jäger W; Cosentini E; Zeitlinger M; Schwameis R
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic activity in microbiological media versus that in human urine: comparison of ampicillin, ciprofloxacin, and trimethoprim-sulfamethoxazole.
    Drobot GR; Karlowsky JA; Hoban DJ; Zhanel GG
    Antimicrob Agents Chemother; 1996 Jan; 40(1):237-40. PubMed ID: 8787914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of subinhibitory concentrations of cefotaxime, imipenem and ciprofloxacin on adhesion of Escherichia coli strains to polystyrene.
    Zalas-Wiecek P; Gospodarek E; Piecyk K
    Pol J Microbiol; 2011; 60(4):345-9. PubMed ID: 22390071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different patterns of bacterial DNA synthesis during postantibiotic effect.
    Gottfredsson M; Erlendsdóttir H; Gudmundsson A; Gudmundsson S
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1314-9. PubMed ID: 7574522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro comparison of ciprofloxacin with other antibiotics against multiresistant gram-negative bacilli].
    Soto Hernández JL; Angeles Morales V; Perea Mejía B; Hernández Velázquez M; Martínez Zubieta R; Pasquel Rivera C
    Rev Invest Clin; 1991; 43(4):318-22. PubMed ID: 1798865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of ciprofloxacin and other antimicrobial drugs on different Escherichia coli strains in continuous-flow cultures under aerobic and anaerobic conditions.
    Bernhardt H; Schulz K; Zimmermann K; Knoke M
    J Antimicrob Chemother; 1998 Aug; 42(2):147-52. PubMed ID: 9738831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Different Peritoneal Dialysis Fluids on the In Vitro Activity of Cefepime, Ciprofloxacin, Ertapenem, Meropenem and Tobramycin Against Escherichia Coli.
    Kussmann M; Schuster L; Wrenger S; Pichler P; Reznicek G; Burgmann H; Poeppl W; Zeitlinger M; Wiesholzer M
    Perit Dial Int; 2016 11-12; 36(6):662-668. PubMed ID: 27680756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal activity of Sch 34343 alone and in combination with gentamicin.
    Shah PM; Schneider K; Stille W
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():165-71. PubMed ID: 3897171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two methods for determining in vitro postantibiotic effects of three antibiotics on Escherichia coli.
    Rescott DL; Nix DE; Holden P; Schentag JJ
    Antimicrob Agents Chemother; 1988 Apr; 32(4):450-3. PubMed ID: 3288112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative determination of minimal inhibitory and bactericidal concentrations of ciprofloxacin, cefotaxime and HR 810 for gram-negative bacteria either sensitive or resistant to ureidopenicillins and/or gentamicin.
    Bartmann K; Tarbuc R
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 May; 259(3):378-89. PubMed ID: 2931927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.